The University of Chicago Header Logo

Connection

S. Margaret Paik to Everolimus

Back to Details
This is a "connection" page, showing publications S. Margaret Paik has written about Everolimus.
S. Margaret Paik
Connection Strength
0.210
Everolimus
  1. Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer. J Clin Oncol. 2024 Sep 01; 42(25):3012-3021.
    View in: PubMed
    Score: 0.210
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.